CoChat

AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts

Sacchi, Nicoletta, Nisson, Paul E., Watkins, Paul C., Faustinella, Fabrizia, Wijsman, Jacqueline, Hagemeijer, Anne · 1994 · Genes, Chromosomes and Cancer
Cited by 43

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The t(3;21)(q26;q22) is associated with chronic myelogenous leukemia in blast crisis (CML‐BC), leukemia evolving from (therapy‐related) myelodysplasia, and with leukemia following other hematopoietic proliferate diseases. Molecular cytogenetic analysis and cloning of a few t(3;21) cases indicate that the breakpoints are quite heterogeneous even within a specific clinical phenotype. Interestingly some of the (3;21) breakpoints involve the AMLI gene previously found rearranged in the t(8;21) associated with acute myelogenous leukemia. AMLI is related to the Drosophila gene runt and is the human counterpart of the gene for the α subunit of the nuclear polyoma enhancer binding protein (PEBP2) also known as the core binding factor (CBF). In the t(3;21) AMLI was found rearranged with EAP, a gene on chromosome 3 encoding a small ribosomal protein, as well as with EVII, another gene on chromosome 3. Here we report our study of six cases of t(3;21). By using fluorescence in situ hybridization (FISH) analysis and AMLI probes we could conclude that at least in two CML‐BC cases the breakpoint occurred in the AMLI intron that is disrupted by the t(8;21). An AMLI/EAP fusion transcript, different from the one described in a therapy‐related myelodysplasia, was detected in both CML‐BC cases. This transcript is expected to result in a predicted protein containing the AMLI nuclear binding domain with an attached stretch of 17 amino acids unrelated to the EAP small ribosomal protein. In the other t(3;21) patients we could not detect an AMLI/EAP transcript or an AMLI/EVII transcript. This result suggests heterogeneity of the t(3;21) at the molecular level. The AMLI chimeric transcripts identified so far, both in the t(3;21) and in the t(8;21), diverge from the normal transcripts either after exon 5 or exon 6. Here we show that in normal AMLI transcripts different splicing events are seen to occur after AMLI exon 5 as well as exon 6.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gcc.2870110405

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 43

Metadata

Authors
Sacchi, N., Nisson, P. E., Watkins, P. C., Faustinella, F., Wijsman, J., & Hagemeijer, A.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
1994-12
Volume
11
Issue
4
Pages
226-236
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2041662181
Cited by
43
References
8
FWCI
2.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts. https://app.cochat.ai/papers/10.1002/gcc.2870110405
The paper
Sacchi, N., Nisson, P. E., Watkins, P. C., Faustinella, F., Wijsman, J., & Hagemeijer, A. (1994). AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.2870110405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.